The results of the current study showed that the treatment of EAC-bearing mice with Cis induced marked increases in the MST and ILS%, with significant decreases in the final body weight and abdominal circumference values, ascetic fluid volume, and viable EAC cells count, in addition to the significant reduction in the level of the serum tumor marker, CEA. The gene discussed is CEACAM5; the disease is neoplasm.